“Giving away money at that pace will not be easy,” says Amir Pasic, dean of the Lilly Family School of Philanthropy at Indiana University ... including the Burlington Northern Santa Fe ...

Despite a weaker-than-expected full-year forecast, shares of Burlington Stores (BURL ... signed an agreement with Eli Lilly’s (LLY) LillyDirect pharmacy partner, Gifthealth, to help streamline ...

Despite a weaker-than-expected full-year forecast, shares of Burlington Stores (BURL ... Additionally, Teladoc Health (TDOC) signed an agreement with Eli Lilly’s (LLY) LillyDirect pharmacy partner, ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

In May 2024, Eli Lilly more than doubled its investment in its Lebanon, Indiana, manufacturing site with a new $5.3 billion commitment, increasing its total investment from $3.7 billion to $9 billion.

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Indiana. And as it begins producing medicines there, potentially as early as next year, that could help boost its sales. Eli Lilly is still in the early stages of its growth when it comes to GLP-1 ...

INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in starting, ...

INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in ...

INDIANAPOLIS — Eli Lilly and Company has announced plans to build four new pharmaceutical sites in the United States, according to a press release from Lilly. The positions are reported to be ...

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...